Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 32 | 2024 | 2003 | 4.280 |
Why?
|
Heart Valve Prosthesis Implantation | 22 | 2024 | 1553 | 3.470 |
Why?
|
Aortic Valve | 23 | 2024 | 1955 | 2.240 |
Why?
|
Myocardial Infarction | 26 | 2023 | 11459 | 1.810 |
Why?
|
Shock, Cardiogenic | 12 | 2023 | 709 | 1.780 |
Why?
|
Mitral Valve Insufficiency | 10 | 2024 | 1400 | 1.760 |
Why?
|
Patient Readmission | 20 | 2023 | 3269 | 1.530 |
Why?
|
Tricuspid Valve | 3 | 2024 | 409 | 1.450 |
Why?
|
Plasma Kallikrein | 3 | 2016 | 21 | 1.320 |
Why?
|
Hospital Mortality | 48 | 2024 | 5293 | 1.280 |
Why?
|
Ischemic Attack, Transient | 3 | 2023 | 874 | 1.240 |
Why?
|
Myocardial Revascularization | 6 | 2020 | 790 | 0.990 |
Why?
|
Cardiovascular Agents | 5 | 2020 | 839 | 0.980 |
Why?
|
Hospital Costs | 14 | 2021 | 947 | 0.920 |
Why?
|
Inpatients | 18 | 2020 | 2544 | 0.840 |
Why?
|
Ischemia | 3 | 2021 | 1884 | 0.820 |
Why?
|
Postoperative Complications | 20 | 2024 | 15612 | 0.820 |
Why?
|
Mitral Valve | 10 | 2024 | 1464 | 0.810 |
Why?
|
Myocardial Ischemia | 7 | 2023 | 2110 | 0.790 |
Why?
|
Endovascular Procedures | 7 | 2020 | 2182 | 0.780 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 208 | 0.750 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 42 | 0.740 |
Why?
|
Databases, Factual | 25 | 2024 | 7960 | 0.740 |
Why?
|
Vascular Grafting | 2 | 2020 | 162 | 0.730 |
Why?
|
Treatment Outcome | 70 | 2024 | 64568 | 0.720 |
Why?
|
Acute Coronary Syndrome | 4 | 2021 | 2190 | 0.700 |
Why?
|
Stroke | 13 | 2024 | 9712 | 0.700 |
Why?
|
Risk Factors | 72 | 2024 | 74115 | 0.690 |
Why?
|
Intracranial Embolism | 1 | 2021 | 187 | 0.680 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2024 | 352 | 0.670 |
Why?
|
Plaque, Atherosclerotic | 2 | 2021 | 1532 | 0.670 |
Why?
|
Registries | 12 | 2023 | 8207 | 0.660 |
Why?
|
Coronary Artery Bypass | 9 | 2021 | 2188 | 0.650 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1271 | 0.650 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 266 | 0.640 |
Why?
|
Peripartum Period | 2 | 2017 | 137 | 0.640 |
Why?
|
United States | 74 | 2024 | 72272 | 0.630 |
Why?
|
Heart Failure | 9 | 2022 | 11669 | 0.610 |
Why?
|
Cardiology | 5 | 2023 | 1656 | 0.610 |
Why?
|
Antithrombins | 1 | 2021 | 292 | 0.610 |
Why?
|
Time Factors | 44 | 2024 | 39913 | 0.600 |
Why?
|
Aged, 80 and over | 52 | 2024 | 58894 | 0.600 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1028 | 0.600 |
Why?
|
Aminopyridines | 2 | 2012 | 573 | 0.580 |
Why?
|
Propensity Score | 10 | 2021 | 1911 | 0.580 |
Why?
|
Risk Assessment | 31 | 2024 | 23972 | 0.580 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2018 | 273 | 0.570 |
Why?
|
Catheterization, Peripheral | 2 | 2022 | 343 | 0.570 |
Why?
|
Heart Valve Prosthesis | 7 | 2020 | 1462 | 0.560 |
Why?
|
Atrial Appendage | 4 | 2021 | 278 | 0.560 |
Why?
|
Incidence | 31 | 2024 | 21337 | 0.550 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2020 | 2118 | 0.530 |
Why?
|
Malnutrition | 1 | 2022 | 622 | 0.520 |
Why?
|
Drug-Eluting Stents | 3 | 2018 | 681 | 0.520 |
Why?
|
Humans | 157 | 2024 | 760617 | 0.520 |
Why?
|
Radial Artery | 2 | 2022 | 187 | 0.520 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2014 | 223 | 0.510 |
Why?
|
Aged | 83 | 2024 | 169042 | 0.500 |
Why?
|
Length of Stay | 21 | 2021 | 6418 | 0.500 |
Why?
|
Specialty Boards | 1 | 2017 | 235 | 0.500 |
Why?
|
Hospitals | 5 | 2021 | 3877 | 0.490 |
Why?
|
Cardiovascular Diseases | 9 | 2021 | 15498 | 0.490 |
Why?
|
Puerperal Disorders | 2 | 2017 | 300 | 0.490 |
Why?
|
Kininogen, High-Molecular-Weight | 2 | 2011 | 6 | 0.480 |
Why?
|
Coronary Angiography | 8 | 2021 | 4470 | 0.470 |
Why?
|
Extremities | 2 | 2021 | 867 | 0.470 |
Why?
|
Endocarditis | 1 | 2018 | 348 | 0.460 |
Why?
|
Odds Ratio | 16 | 2021 | 9643 | 0.460 |
Why?
|
Heart Aneurysm | 1 | 2014 | 114 | 0.440 |
Why?
|
Certification | 1 | 2017 | 418 | 0.440 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1924 | 0.440 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 512 | 0.440 |
Why?
|
Heart Arrest | 4 | 2017 | 1513 | 0.430 |
Why?
|
Femoral Artery | 2 | 2022 | 826 | 0.430 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 487 | 0.420 |
Why?
|
Saphenous Vein | 1 | 2016 | 516 | 0.420 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 537 | 0.410 |
Why?
|
Retrospective Studies | 55 | 2024 | 80566 | 0.400 |
Why?
|
Survival Rate | 18 | 2019 | 12719 | 0.400 |
Why?
|
Male | 99 | 2024 | 360358 | 0.400 |
Why?
|
Septal Occluder Device | 3 | 2021 | 125 | 0.390 |
Why?
|
Hospitalization | 9 | 2021 | 10704 | 0.390 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1927 | 0.390 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2011 | 24 | 0.390 |
Why?
|
Female | 98 | 2024 | 392148 | 0.370 |
Why?
|
Patient Care Team | 2 | 2020 | 2515 | 0.370 |
Why?
|
Patient Discharge | 9 | 2021 | 3442 | 0.370 |
Why?
|
Atrial Fibrillation | 8 | 2024 | 5031 | 0.360 |
Why?
|
Magnesium | 1 | 2014 | 804 | 0.360 |
Why?
|
Cardiac Surgical Procedures | 2 | 2023 | 3621 | 0.360 |
Why?
|
Skilled Nursing Facilities | 4 | 2021 | 399 | 0.360 |
Why?
|
Forecasting | 2 | 2018 | 2924 | 0.350 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 805 | 0.350 |
Why?
|
Electrocardiography | 9 | 2018 | 6346 | 0.340 |
Why?
|
Angina, Unstable | 1 | 2013 | 888 | 0.330 |
Why?
|
Coronary Artery Disease | 6 | 2020 | 6403 | 0.320 |
Why?
|
Cardiotonic Agents | 2 | 2015 | 539 | 0.320 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2745 | 0.320 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2916 | 0.300 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 829 | 0.300 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3410 | 0.300 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2019 | 92 | 0.300 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1580 | 0.290 |
Why?
|
Lipopolysaccharides | 2 | 2012 | 2202 | 0.290 |
Why?
|
Contrast Media | 2 | 2020 | 5305 | 0.280 |
Why?
|
Logistic Models | 11 | 2021 | 13245 | 0.280 |
Why?
|
Middle Aged | 55 | 2021 | 220584 | 0.280 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3680 | 0.270 |
Why?
|
Blood Coagulation | 1 | 2012 | 1154 | 0.260 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 2 | 2020 | 131 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2021 | 2249 | 0.250 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 576 | 0.250 |
Why?
|
Erythrocyte Transfusion | 2 | 2020 | 568 | 0.240 |
Why?
|
Comorbidity | 12 | 2021 | 10505 | 0.240 |
Why?
|
Cause of Death | 6 | 2021 | 3683 | 0.230 |
Why?
|
Morbidity | 6 | 2019 | 1750 | 0.230 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3705 | 0.230 |
Why?
|
Cardiomyopathies | 4 | 2018 | 1948 | 0.230 |
Why?
|
Influenza, Human | 3 | 2021 | 1518 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2020 | 1310 | 0.220 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1884 | 0.220 |
Why?
|
Disease Management | 3 | 2021 | 2506 | 0.220 |
Why?
|
International Classification of Diseases | 2 | 2021 | 909 | 0.210 |
Why?
|
Secondary Prevention | 2 | 2021 | 1469 | 0.200 |
Why?
|
American Heart Association | 3 | 2023 | 1039 | 0.200 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2018 | 763 | 0.200 |
Why?
|
Follow-Up Studies | 16 | 2021 | 39063 | 0.190 |
Why?
|
Endothelial Cells | 2 | 2011 | 3548 | 0.190 |
Why?
|
Kidney Failure, Chronic | 4 | 2018 | 2477 | 0.190 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.190 |
Why?
|
Cost of Illness | 4 | 2020 | 1935 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2024 | 421 | 0.180 |
Why?
|
Atrial Septum | 1 | 2021 | 60 | 0.180 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2024 | 852 | 0.180 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3873 | 0.180 |
Why?
|
Multivariate Analysis | 7 | 2021 | 12043 | 0.180 |
Why?
|
Arrhythmias, Cardiac | 2 | 2024 | 2234 | 0.170 |
Why?
|
Epoprostenol | 2 | 2011 | 247 | 0.170 |
Why?
|
Age Factors | 8 | 2021 | 18381 | 0.170 |
Why?
|
Renal Dialysis | 3 | 2018 | 1799 | 0.170 |
Why?
|
Coronary Vessels | 2 | 2021 | 3095 | 0.170 |
Why?
|
Sepsis | 2 | 2021 | 2585 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1241 | 0.170 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 42 | 0.170 |
Why?
|
Nutrition Assessment | 1 | 2022 | 726 | 0.160 |
Why?
|
Hypertension | 5 | 2021 | 8529 | 0.160 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2017 | 992 | 0.160 |
Why?
|
Coronary Disease | 2 | 2023 | 5912 | 0.160 |
Why?
|
Sex Factors | 6 | 2021 | 10548 | 0.160 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 219 | 0.160 |
Why?
|
Stents | 2 | 2021 | 3178 | 0.160 |
Why?
|
Mitral Valve Prolapse | 1 | 2020 | 212 | 0.150 |
Why?
|
Renal Artery | 1 | 2020 | 351 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 284 | 0.150 |
Why?
|
Death | 1 | 2022 | 674 | 0.150 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 188 | 0.150 |
Why?
|
Tachycardia, Ventricular | 2 | 2018 | 1261 | 0.140 |
Why?
|
Prevalence | 9 | 2021 | 15689 | 0.140 |
Why?
|
Denmark | 1 | 2019 | 770 | 0.140 |
Why?
|
Hemorrhage | 5 | 2023 | 3418 | 0.140 |
Why?
|
Patient Admission | 2 | 2015 | 1365 | 0.140 |
Why?
|
Endarterectomy | 1 | 2017 | 196 | 0.140 |
Why?
|
Echocardiography | 4 | 2019 | 4987 | 0.140 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1866 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 10199 | 0.140 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2018 | 90 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2021 | 1155 | 0.140 |
Why?
|
New Mexico | 1 | 2016 | 83 | 0.140 |
Why?
|
Antigens, CD34 | 1 | 2018 | 658 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.130 |
Why?
|
Rhode Island | 1 | 2016 | 351 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15828 | 0.130 |
Why?
|
Heart-Assist Devices | 2 | 2017 | 1288 | 0.120 |
Why?
|
Bioprosthesis | 1 | 2019 | 591 | 0.120 |
Why?
|
Rural Population | 2 | 2022 | 2276 | 0.120 |
Why?
|
Punctures | 1 | 2016 | 364 | 0.120 |
Why?
|
Prognosis | 8 | 2019 | 29600 | 0.120 |
Why?
|
Patient Selection | 2 | 2024 | 4237 | 0.120 |
Why?
|
Health Status Disparities | 4 | 2020 | 1846 | 0.120 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4236 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 959 | 0.110 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 48 | 0.110 |
Why?
|
Nutritional Status | 1 | 2022 | 1596 | 0.110 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1204 | 0.110 |
Why?
|
Exercise Test | 1 | 2021 | 2127 | 0.110 |
Why?
|
Coronary Circulation | 1 | 2020 | 1569 | 0.110 |
Why?
|
Medicaid | 2 | 2018 | 2814 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 735 | 0.110 |
Why?
|
Catheter Ablation | 2 | 2018 | 2634 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6305 | 0.110 |
Why?
|
Acetanilides | 1 | 2014 | 169 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2020 | 859 | 0.100 |
Why?
|
Patient Transfer | 2 | 2018 | 793 | 0.100 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1085 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2023 | 283 | 0.100 |
Why?
|
Age Distribution | 4 | 2020 | 2871 | 0.100 |
Why?
|
Sex Distribution | 4 | 2018 | 2278 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1299 | 0.100 |
Why?
|
Quality Improvement | 2 | 2019 | 3797 | 0.100 |
Why?
|
Medicare | 2 | 2024 | 6765 | 0.100 |
Why?
|
Nitric Oxide | 2 | 2011 | 2135 | 0.100 |
Why?
|
Stroke Volume | 2 | 2023 | 5486 | 0.100 |
Why?
|
Drug Costs | 1 | 2020 | 1183 | 0.100 |
Why?
|
Kidney | 2 | 2017 | 7045 | 0.100 |
Why?
|
Prekallikrein | 1 | 2011 | 11 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 448 | 0.100 |
Why?
|
Blood Coagulation Disorders | 1 | 2015 | 350 | 0.100 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2012 | 186 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 428 | 0.090 |
Why?
|
Emergencies | 1 | 2018 | 1217 | 0.090 |
Why?
|
Maternal Mortality | 1 | 2014 | 301 | 0.090 |
Why?
|
Calcinosis | 1 | 2020 | 1469 | 0.090 |
Why?
|
Signal Transduction | 2 | 2011 | 23416 | 0.090 |
Why?
|
Health Resources | 1 | 2017 | 933 | 0.090 |
Why?
|
Hemodynamics | 2 | 2020 | 4160 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2017 | 794 | 0.090 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1349 | 0.090 |
Why?
|
Bradykinin | 1 | 2011 | 208 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 601 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1483 | 0.090 |
Why?
|
Smoking | 3 | 2021 | 9050 | 0.090 |
Why?
|
Verapamil | 1 | 2011 | 242 | 0.090 |
Why?
|
Creatinine | 1 | 2016 | 1896 | 0.090 |
Why?
|
Cohort Studies | 4 | 2022 | 41457 | 0.090 |
Why?
|
Adult | 22 | 2021 | 220969 | 0.090 |
Why?
|
Phenylephrine | 1 | 2011 | 293 | 0.090 |
Why?
|
Drug Combinations | 1 | 2016 | 2048 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1120 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2778 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1239 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5491 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1489 | 0.090 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 699 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1998 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1790 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.080 |
Why?
|
Heart Conduction System | 1 | 2015 | 992 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10754 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15251 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1956 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7237 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 1068 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1185 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2016 | 2114 | 0.080 |
Why?
|
Recurrence | 2 | 2018 | 8426 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2178 | 0.080 |
Why?
|
Home Care Services | 1 | 2015 | 648 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2595 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 2 | 2021 | 488 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1551 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4117 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1701 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4785 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1790 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2011 | 973 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2018 | 1722 | 0.070 |
Why?
|
Obesity | 3 | 2021 | 12933 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2015 | 1462 | 0.070 |
Why?
|
Nursing Homes | 1 | 2014 | 1083 | 0.070 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5835 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2090 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2011 | 1200 | 0.070 |
Why?
|
Gadolinium | 1 | 2011 | 959 | 0.070 |
Why?
|
Rabbits | 1 | 2012 | 4770 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7871 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3351 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3194 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3028 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2568 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2011 | 18937 | 0.060 |
Why?
|
Rats | 2 | 2012 | 23717 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3516 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2491 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3592 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2812 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4321 | 0.060 |
Why?
|
Heart Transplantation | 2 | 2015 | 3232 | 0.060 |
Why?
|
Pregnancy | 2 | 2017 | 29868 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18221 | 0.060 |
Why?
|
Thrombosis | 2 | 2021 | 2943 | 0.050 |
Why?
|
Piperazines | 1 | 2014 | 2521 | 0.050 |
Why?
|
Plasmapheresis | 2 | 2015 | 206 | 0.050 |
Why?
|
Young Adult | 7 | 2022 | 59179 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2921 | 0.050 |
Why?
|
Kinetics | 1 | 2011 | 6370 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3321 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2021 | 3209 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4433 | 0.050 |
Why?
|
Health Status | 3 | 2020 | 4075 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 274 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 88234 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8166 | 0.050 |
Why?
|
Chronic Disease | 3 | 2023 | 9311 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3879 | 0.050 |
Why?
|
Software | 1 | 2015 | 4431 | 0.050 |
Why?
|
Superinfection | 1 | 2021 | 63 | 0.050 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 206 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4845 | 0.040 |
Why?
|
Learning Curve | 1 | 2021 | 230 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4671 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 697 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 304 | 0.040 |
Why?
|
Mortality | 2 | 2022 | 2899 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5866 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 316 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4803 | 0.040 |
Why?
|
Splanchnic Circulation | 1 | 2019 | 119 | 0.040 |
Why?
|
Calcium | 1 | 2011 | 5717 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5146 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 2017 | 338 | 0.030 |
Why?
|
Animals | 3 | 2014 | 168201 | 0.030 |
Why?
|
Normal Distribution | 1 | 2017 | 272 | 0.030 |
Why?
|
Equipment Design | 1 | 2024 | 3501 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2017 | 490 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 473 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 770 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 849 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1315 | 0.030 |
Why?
|
Dobutamine | 1 | 2015 | 116 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5878 | 0.030 |
Why?
|
Endarterectomy, Carotid | 1 | 2020 | 554 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22131 | 0.030 |
Why?
|
Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.030 |
Why?
|
Systole | 1 | 2017 | 935 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2021 | 929 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 928 | 0.030 |
Why?
|
Shock, Septic | 1 | 2021 | 769 | 0.030 |
Why?
|
India | 1 | 2021 | 2286 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1197 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 2015 | 172 | 0.030 |
Why?
|
Radiation Protection | 1 | 2017 | 424 | 0.030 |
Why?
|
New York | 1 | 2016 | 874 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 615 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2021 | 868 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2015 | 385 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2112 | 0.030 |
Why?
|
Hospital Charges | 1 | 2015 | 350 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2018 | 836 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1504 | 0.030 |
Why?
|
Nitrates | 1 | 2014 | 263 | 0.030 |
Why?
|
Utilization Review | 1 | 2014 | 382 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1663 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4010 | 0.030 |
Why?
|
Cost Savings | 1 | 2017 | 912 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1230 | 0.020 |
Why?
|
Uncertainty | 1 | 2017 | 752 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2392 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 414 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1257 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54360 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10760 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 809 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 694 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20556 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 962 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 664 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2018 | 1160 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3117 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2630 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1835 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2218 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2495 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2925 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3599 | 0.020 |
Why?
|
Disabled Persons | 1 | 2018 | 1226 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2978 | 0.020 |
Why?
|
Body Mass Index | 2 | 2016 | 12943 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1632 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1048 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1091 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4037 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9604 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3370 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1347 | 0.020 |
Why?
|
Warfarin | 1 | 2015 | 1477 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2756 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 3016 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7798 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6474 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3796 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4174 | 0.010 |
Why?
|
Critical Care | 1 | 2014 | 2690 | 0.010 |
Why?
|
Blood Pressure | 1 | 2017 | 8472 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13347 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36152 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26049 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42188 | 0.010 |
Why?
|
Child | 1 | 2018 | 80079 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36402 | 0.000 |
Why?
|